Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 16, Pages 7926-7931
Publisher
Proceedings of the National Academy of Sciences
Online
2019-03-30
DOI
10.1073/pnas.1820892116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
- (2018) Antonio M. Risitano et al. AMERICAN JOURNAL OF HEMATOLOGY
- The role of the alternative pathway of complement activation in glomerular diseases
- (2018) Emilia Łukawska et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
- (2018) Wentian Luo et al. Frontiers in Immunology
- Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
- (2017) Michela Sica et al. Journal of Hematology & Oncology
- Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study
- (2016) Michael Loschi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation
- (2016) Markus J. Harder et al. BLOOD
- Small-molecule factor D inhibitors targeting the alternative complement pathway
- (2016) Jürgen Maibaum et al. Nature Chemical Biology
- Paroxysmal nocturnal hemoglobinuria
- (2014) R. A. Brodsky BLOOD
- Genetic variants in the complement system predisposing to age-related macular degeneration: A review
- (2014) Elizabeth C. Schramm et al. MOLECULAR IMMUNOLOGY
- Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)
- (2014) Marta Hidalgo et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Recent insights into C3 glomerulopathy
- (2013) Thomas D. Barbour et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
- (2012) Y. Zhang et al. Clinical Journal of the American Society of Nephrology
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
- (2010) F. Forneris et al. SCIENCE
- Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
- (2009) A. M. Risitano et al. BLOOD
- Structure−Activity Relationships for Substrate-Based Inhibitors of Human Complement Factor B
- (2009) Gloria Ruiz-Gómez et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor
- (2009) Suzan H M Rooijakkers et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now